HEADER RIBONUCLEOTIDE REDUCTASE 13-MAR-97 1AFT TITLE SMALL SUBUNIT C-TERMINAL INHIBITORY PEPTIDE OF MOUSE RIBONUCLEOTIDE TITLE 2 REDUCTASE AS BOUND TO THE LARGE SUBUNIT, NMR, 26 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL RESIDUES AC-FTLDADF OF SMALL SUBUNIT; COMPND 5 EC: 1.17.4.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1 KEYWDS RIBONUCLEOTIDE REDUCTASE, PEPTIDE INHIBITORS, TRANSFERRED NOESY, KEYWDS 2 RESTRAINED MOLECULAR DYNAMICS, NONSTANDARD TYPE I TURN EXPDTA SOLUTION NMR NUMMDL 26 AUTHOR P.B.LAUB,A.L.FISHER,G.T.FURST,B.A.BARWIS,C.S.HAMANN,B.S.COOPERMAN REVDAT 4 30-OCT-24 1AFT 1 LINK REVDAT 3 29-NOV-17 1AFT 1 REMARK HELIX REVDAT 2 24-FEB-09 1AFT 1 VERSN REVDAT 1 15-MAY-97 1AFT 0 JRNL AUTH A.FISHER,P.B.LAUB,B.S.COOPERMAN JRNL TITL NMR STRUCTURE OF AN INHIBITORY R2 C-TERMINAL PEPTIDE BOUND JRNL TITL 2 TO MOUSE RIBONUCLEOTIDE REDUCTASE R1 SUBUNIT. JRNL REF NAT.STRUCT.BIOL. V. 2 951 1995 JRNL REFN ISSN 1072-8368 JRNL PMID 7583667 JRNL DOI 10.1038/NSB1195-951 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.0 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SEE JRNL REFERENCE FOR REFINEMENT REMARK 3 DETAILS. THE AUTHORS DID NOT MAKE OR ATTEMPT TO MAKE REMARK 3 STEREOSPECIFIC ASSIGNMENTS. REMARK 4 REMARK 4 1AFT COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170762. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 287 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : TRNOESY; TOCSY; ROESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX500; DMX500; AMX600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XPLOR REMARK 210 METHOD USED : SIMULATED ANNEALING IMPLEMENTED REMARK 210 WITH RESTRAINED MOLECULAR REMARK 210 DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 299 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 26 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATIONS, REMARK 210 POTENTIAL ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 2 59.06 -116.61 REMARK 500 1 LEU A 3 44.73 -91.52 REMARK 500 1 ASP A 6 -54.74 122.49 REMARK 500 2 THR A 2 62.17 -114.48 REMARK 500 2 LEU A 3 39.37 -87.47 REMARK 500 2 ASP A 6 -31.39 122.10 REMARK 500 3 THR A 2 62.16 -114.68 REMARK 500 3 LEU A 3 40.11 -87.60 REMARK 500 3 ASP A 6 -31.68 123.64 REMARK 500 4 THR A 2 60.50 -115.66 REMARK 500 4 LEU A 3 42.25 -89.94 REMARK 500 4 ASP A 4 -44.05 -131.07 REMARK 500 4 ASP A 6 -34.08 123.86 REMARK 500 5 THR A 2 59.52 -115.48 REMARK 500 5 LEU A 3 42.36 -90.47 REMARK 500 5 ASP A 4 -43.87 -130.73 REMARK 500 5 ASP A 6 -33.67 122.81 REMARK 500 6 THR A 2 67.65 -117.52 REMARK 500 6 LEU A 3 40.19 -83.24 REMARK 500 6 ASP A 4 -46.06 -130.03 REMARK 500 6 ASP A 6 37.92 106.69 REMARK 500 7 THR A 2 59.26 -116.41 REMARK 500 7 LEU A 3 43.31 -91.49 REMARK 500 7 ASP A 6 -31.88 122.76 REMARK 500 8 THR A 2 61.38 -115.99 REMARK 500 8 LEU A 3 42.09 -89.56 REMARK 500 8 ASP A 4 -43.70 -130.89 REMARK 500 8 ASP A 6 -32.43 124.05 REMARK 500 9 THR A 2 62.47 -115.02 REMARK 500 9 LEU A 3 40.00 -87.35 REMARK 500 9 ASP A 6 -31.57 122.80 REMARK 500 10 THR A 2 63.08 -115.73 REMARK 500 10 LEU A 3 43.18 -88.39 REMARK 500 10 ASP A 4 -44.84 -130.38 REMARK 500 10 ASP A 6 -33.33 117.48 REMARK 500 11 THR A 2 52.45 -117.77 REMARK 500 11 LEU A 3 40.17 -93.86 REMARK 500 11 ASP A 6 -33.30 124.58 REMARK 500 12 THR A 2 58.31 -115.98 REMARK 500 12 LEU A 3 41.64 -90.23 REMARK 500 12 ASP A 4 -44.21 -131.65 REMARK 500 12 ASP A 6 -33.33 121.13 REMARK 500 13 THR A 2 60.44 -117.19 REMARK 500 13 LEU A 3 43.78 -83.11 REMARK 500 13 ASP A 4 -44.80 -133.71 REMARK 500 14 THR A 2 51.77 -118.05 REMARK 500 14 LEU A 3 38.15 -93.90 REMARK 500 14 ASP A 6 -32.84 122.64 REMARK 500 15 THR A 2 61.01 -115.41 REMARK 500 15 LEU A 3 41.58 -90.06 REMARK 500 REMARK 500 THIS ENTRY HAS 92 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1AFT A 1 7 UNP P11157 RIR2_MOUSE 384 390 SEQRES 1 A 8 ACE PHE THR LEU ASP ALA ASP PHE HET ACE A 0 6 HETNAM ACE ACETYL GROUP FORMUL 1 ACE C2 H4 O LINK C ACE A 0 N PHE A 1 1555 1555 1.30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 C ACE A 0 -5.084 -5.184 -1.245 1.00 0.00 C HETATM 2 O ACE A 0 -6.258 -5.289 -0.946 1.00 0.00 O HETATM 3 CH3 ACE A 0 -4.530 -5.884 -2.469 1.00 0.00 C HETATM 4 H1 ACE A 0 -4.967 -5.440 -3.349 1.00 0.00 H HETATM 5 H2 ACE A 0 -4.783 -6.931 -2.412 1.00 0.00 H HETATM 6 H3 ACE A 0 -3.458 -5.762 -2.483 1.00 0.00 H